Curcumin absorption
March 5, 2014
Whilst the inflammatory action
of curcumin has been shown in
over 4000 scientific articles, a
significant hurdle for scientists
has been formulating a way for
curcumin to be readily absorbed by
the body.
In an Australian first, a new
patented method has been
discovered where curcumin is
absorbed at 27 times the normal
rate, increasing anti-inflammatory
activity, BioCeuticals has said.
The new curcumin preparation is
the clinically trialled practitioneronly
Theracurmin BioActive
300mg, by BioCeuticals, shown to
help down-regulate inflammatory
mediators and reduce joint
inflammation.
A meta-analysis published in
Phototherapy Research in June
2013, comprising 172 subjects,
showed that curcuminoids were
associated with a significant
reduction in circulating
inflammatory (C-reactive protein
CRP) levels.
Prof Marc Cohen from the
School of Health Sciences at RMIT
University said, “Curcumin is
one of the most profound antiinflammatory
agents we know
of today and has been shown to
inhibit almost all inflammatory
mediators in the body.”
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Mar 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Mar 14
